Top Markets
Coin of the day
Komipharm International Co., Ltd. Komipharm International Co., Ltd.

Komipharm International Co., Ltd.

041960
Rank in Stocks #13767
Komipharm International Co., Ltd. is a South Korean biopharmaceutical firm... Komipharm International Co., Ltd. is a South Korean biopharmaceutical firm specializing in the research, development, and production of veterinary pharmaceuticals and animal vaccines. Their extensive portfolio features vaccines designed for livestock like swine, cattle, and poultry, as well as companion animals such as canines. Complementing these, they offer antibiotics, disinfectants, and bio-fertilizers, in addition to providing clinical laboratory services. The company is also expanding its focus to human health, with ongoing development of anticancer drugs and pain management agents.
Share Price
$6.44
Market Cap
$462.75M
Change (1 day)
0.54%
Change (1 year)
49.78%
Country
KR
Trade Komipharm International Co., Ltd. (041960)

Category

Operating Margin for Komipharm International Co., Ltd. (041960)
Operating Margin as of 2026 TTM: 0.00%
According to Komipharm International Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Komipharm International Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
62.34% -
US
0.00% -
SE
0.00% -
FR
0.00% -
IT
21.84% -
HK
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.